Intra-Cellular Therapies, Inc.

JPMORGAN CHASE & CO

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/12/2025

Shares

759,991

Value ($000)

100,258

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/12/2025	100,258	0.0%	759,991	3/31/2025
2024 Q4	2/12/2025	428,131	0.0%	5,126,092	12/31/2024
2024 Q3	11/8/2024	386,798	0.0%	5,286,285	9/30/2024
2024 Q2	8/12/2024	235,279	0.0%	3,435,232	6/30/2024
2024 Q1	5/10/2024	121,512	0.0%	1,755,948	3/31/2024
2023 Q4	2/12/2024	148,441	0.0%	2,072,615	12/31/2023
2023 Q3	11/14/2023	107,503	0.0%	2,063,802	9/30/2023
2023 Q2	8/11/2023	125,210	0.0%	1,977,414	6/30/2023
2023 Q1	5/18/2023	99,143	0.0%	1,830,884	3/31/2023
2022 Q4	2/13/2023	79,269	0.0%	1,497,914	12/31/2022
2022 Q3	11/14/2022	8,738	0.0%	187,784	9/30/2022
2022 Q2	8/11/2022	10,800	0.0%	189,217	6/30/2022
2022 Q1	5/11/2022	9,615	0.0%	157,144	3/31/2022
2021 Q4	2/11/2022	7,364	0.0%	140,690	12/31/2021
2021 Q3	11/12/2021	5,293	0.0%	142,003	9/30/2021
2021 Q2	8/12/2021	5,881	0.0%	144,094	6/30/2021
2021 Q1	5/12/2021	5,070	0.0%	149,403	3/31/2021
2020 Q4	2/19/2021	5,075	0.0%	159,603	12/31/2020
2020 Q3	11/12/2020	4,177	0.0%	163,543	9/30/2020
2020 Q2	8/11/2020	4,268	0.0%	166,262	6/30/2020
2020 Q1	5/12/2020	2,520	0.0%	164,001	3/31/2020
2019 Q4	2/11/2020	13,014	0.0%	379,319	12/31/2019